Search details
1.
Degree of joint risk factor control and hazard of mortality in diabetes patients: a matched cohort study in UK Biobank.
BMC Med
; 22(1): 108, 2024 Mar 07.
Article
in English
| MEDLINE | ID: mdl-38454415
2.
Effects of Non-Face-to-Face Chronic Care Management on Service Utilization and Outcomes Among US Medicare Beneficiaries with Diabetes.
J Gen Intern Med
; 2024 Feb 21.
Article
in English
| MEDLINE | ID: mdl-38381242
3.
An exploratory analysis of the cost-effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model.
Diabet Med
; 41(5): e15303, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38470100
4.
Risk factor control and incident cardiovascular disease in patients with diabetes: Sex-specific relations.
Diabetes Obes Metab
; 26(4): 1421-1429, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38229469
5.
5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.
Diabetes Obes Metab
; 26(2): 463-472, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37867175
6.
Cumulative effect of metabolic risk factors on left ventricular geometry in those with versus without early-onset type 2 diabetes or prediabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Diabetes Obes Metab
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38837542
7.
Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data.
Diabetes Obes Metab
; 26(4): 1502-1509, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38297986
8.
Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients.
Eur Heart J
; 44(28): 2583-2591, 2023 07 21.
Article
in English
| MEDLINE | ID: mdl-37385629
9.
Vasoactive mediators of hypertension in obesity.
Am J Physiol Endocrinol Metab
; 325(4): E406-E411, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37672250
10.
Weight Loss in Underserved Patients - A Cluster-Randomized Trial.
N Engl J Med
; 383(10): 909-918, 2020 09 03.
Article
in English
| MEDLINE | ID: mdl-32877581
11.
The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes.
Med Care
; 61(3): 157-164, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36728398
12.
Cost-effectiveness analysis of once-daily insulin glargine 300 U/mL versus insulin degludec 100 U/mL using the BRAVO diabetes model.
Diabet Med
; 40(9): e15112, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37035994
13.
A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States.
Diabetes Obes Metab
; 25(10): 2862-2868, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37334525
14.
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Diabetes Obes Metab
; 25(2): 407-416, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36193847
15.
The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana.
Value Health
; 26(5): 676-684, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36216707
16.
Dietary intake during a pragmatic cluster-randomized weight loss trial in an underserved population in primary care.
Nutr J
; 22(1): 38, 2023 08 02.
Article
in English
| MEDLINE | ID: mdl-37528391
17.
Pax4 in Health and Diabetes.
Int J Mol Sci
; 24(9)2023 May 05.
Article
in English
| MEDLINE | ID: mdl-37175989
18.
Effects of a 2-Year Primary Care Lifestyle Intervention on Cardiometabolic Risk Factors: A Cluster-Randomized Trial.
Circulation
; 143(12): 1202-1214, 2021 03 23.
Article
in English
| MEDLINE | ID: mdl-33557578
19.
The trial to assess chelation therapy 2 (TACT2): Rationale and design.
Am Heart J
; 252: 1-11, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35598636
20.
Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM-CURE risk score.
Diabetes Obes Metab
; 24(11): 2203-2211, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35801340